Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

979 – Epigenetic Changes With T. gondii in Brains of People With HIV and Their Possible Link to Gliomas

Background Toxoplasma gondii, a zoonotic parasite, poses risks for people with HIV (PWH). Although its clinical impact is minimal in immunocompetent hosts, U.S. seroprevalence studies show a 20-30% infection rate. The parasite forms bradyzoites in brain and muscle tissue that can reactivate when CD4+ T cell counts drop in PWH, leading to severe disease. Additionally,…

1249 – Risk Factors for Incomplete Treatment for Syphilis in Pregnant Oral PrEP Users in South Africa

Background Understanding the prevalence, risk factors, and barriers to treatment of syphilis in pregnant women is essential to inform the prevention of vertical transmission. Methods Within a clinical trial of PrEP promotion interventions, we enrolled 750 HIV-negative pregnant women aged >16 years and used medical records to examine syphilis testing and treatment. We report the…

958 – Genetics of Plasma Rifapentine Clearance During Pulmonary Tuberculosis Treatment in Study 31/A5349

Background Optimizing rifapentine (RPT) dosing is critical for improving tuberculosis (TB) treatment response. Study 31/A5349 (NCT02410772) compared two 4-month RPT-containing regimens — one with and one without moxifloxacin (MFX) — to the standard 6-month regimen. A key determinant of unfavorable TB outcomes in this trial was RPT exposure, with large interindividual variability. We hypothesized that…

1001 – Impact of Gestational Diabetes on Pregnancy Outcomes in South African Women Living With HIV

Background The prevalence of gestational diabetes (GDM) is increasing globally, including in settings where HIV is prevalent. GDM is associated with pregnancy loss and large-for-gestational age (LGA) deliveries but there are no data on whether these associations are altered by maternal HIV and/or antiretroviral therapy. Methods The ORCHID study enrolled pregnant women with HIV (WLH)…

969 – The Impact of Rifampin Drug Interactions on TPT Completion and Safety Using High-Dose vs Standard

Background Tuberculosis preventive treatment (TPT) has been recognized by the World Health Organization as a critical intervention to eliminate tuberculosis. Rifampin TPT is critical to this goal, given high completion rates, short treatment lengths, and low side-effects. However, rifampin treatment has limitations by drug-drug interactions (DDI) with multiple medications   Methods A post-hoc data analysis…

1012 – The Role of Maternal Broadly Neutralizing Antibody Activity in Perinatal Transmission of HIV-1

Background Despite increased availability to antiretroviral therapy, up to 5% of people living with HIV (PLH) still transmit HIV-1 to the infant. Broadly neutralizing antibodies (bNAbs) are the immunologic goal of HIV-1 vaccine candidates; however, in postnatal cohorts, we have reported the presence of bNAbs targeting a single epitope, which contributes to viral escape. We…

971 – Patient and Provider Preferences for Long-Acting Tuberculosis Preventive Therapy

Background Tuberculosis preventive therapy (TPT) is a key intervention for tuberculosis (TB) elimination. The introduction of long acting (LA) TPT has the potential to enhance adherence, minimize treatment interruptions, improve completion rates, and extend protection against tuberculosis. Methods We conducted a cross-sectional in-person survey among patients in two high-burden TB countries to evaluate preferences, and concerns…

1013 – ART Reverses Negative Natural Selection of HIV Disease-Linked HLA-I in KwaZulu-Natal, South Africa

Background HLA is the most polymorphic region in the human genome, as the differential HLA-dependent impact of certain infections, inflammatory conditions, autoimmune diseases and cancers drive its evolution. However, clear examples of infection-driven evolution are rare. Here, we investigated antenatal cohorts in KwaZulu-Natal (KZN), South Africa, the region most severely affected by the global HIV…

960 – Effectiveness of Portable Digital X-Ray Machine in Tuberculosis Case-Finding in Nigeria

Background The high tuberculosis (TB) burden in Nigeria, particularly in hard-to-reach and underserved areas, has called for innovative approaches to enhance case-finding. The portable digital X-ray (PDX) machines offer an opportunity to improve TB detection in regions with limited resources and access to more complex diagnostic tools. This paper presents the effectiveness of PDX machines in TB case-finding…

955 – Immune Profiles Can Differentiate Mycobacterial and KSHV Inflammatory Syndromes in Advanced HIV

Background Mycobacterial immune reconstitution inflammatory syndrome (myco-IRIS) and Kaposi sarcoma herpesvirus (KSHV) associated diseases (KAD) remain common in people with advanced HIV in resource-constrained settings. These syndromes can be difficult to differentiate clinically, and optimal treatments remain unknown, highlighting the importance of determining their pathogenesis. We have previously shown greater IFNγ production in myco-IRIS whereas IL18…